nicastrin Antibodies

Santa Cruz Biotechnology features a diverse variety of nicastrin monoclonal antibodies for investigating nicastrin's role in cellular processes. nicastrin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nicastrin is a key component of the gamma-secretase complex, participating in the proteolytic processing of type I membrane proteins, including the amyloid precursor protein (APP). The processing of APP by gamma-secretase has significant implications for Alzheimer's disease through the generation of amyloid-beta peptides. Research into nicastrin's molecular interactions and biological functions continues to reveal important insights about neurodegenerative disease mechanisms. Understanding nicastrin's role in gamma-secretase activity may lead to breakthrough therapeutic approaches for treating Alzheimer's disease. Investigating nicastrin expression patterns across different tissues and cellular conditions can provide valuable information about its regulatory mechanisms. Exploring nicastrin's involvement in various signaling pathways helps illuminate its broader biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of nicastrin's role in health and disease.